Akili Interactive Labs and Pfizer are partnering to evaluate patients’ risk of developing Alzheimer’s disease by following their performance while playing a specialized video game, Akili announced Jan. 9.

Despite guideline recommendations, repeating fine-needle aspiration biopsy for thyroid nodules with more than 50 percent growth is unlikely to result in a diagnosis of malignancy, according to a study published online Jan. 16 in Radiology.

Journals that have adopted the Standards for Reporting of Diagnostic Accuracy (STARD) feature CT coronary angiography studies that have been largely successful at complying with manuscript guidelines, according to a study published in the January issue of Radiology.

Biopharmaceutical company Intellect Neurosciences announced Jan. 16 that a potentially disease-modifying tau agent is in the preliminary stages of validation for neurological diseases including Alzheimer’s.

A bill that would increase Alzheimer’s research funding appropriations by $122 million has passed Congress and is now under deliberation by the president.

German research center Helmholtz Zentrum Munchen announced today that the company had successfully finalized three new spin-offs within the past year to include SurgVision, Trianta Immunotherapies and Dosimetrics.

Viztek, a leading provider of complete digital software and hardware diagnostic imaging solutions, today announced that the Platinum Dynamic Fluoroscopy System has received FDA 510(k) clearance.

An ultrasound-CT protocol for appendicitis evaluation provides potentially larger savings over the standard CT-only protocol, according to a study published in the January 2014 issue of the American Journal of Roentgenology.